Evaluation of Cancer Prevention and Treatment Demonstration

The enrollment period for the demonstration began October 2006 across three sites: Detroit, Hawaii and Utah/Montana. Enrollment began one month later for Newark and Baltimore sites. Enrollment at the Houston site began in April 2007. As of November 25, 2009, there were 10,705 active enrollees in the Cancer Prevention and Treatment Demonstration, with a total of 9,964 in the screening arm and 741 in the treatment arm. Site-specific enrollment numbers are below. -Utah/Montana: The Huntsman Cancer Institute reported 1,698 initial CSAs completed. Of the CSAs completed, 1,485 are active enrollees and 213 are disenrolled participants. There are currently 1,485 active enrollees that include 571 screening intervention, 870 screening control, 31 treatment intervention, and 13 treatment control. Huntsman conducted 489 annual CSAs and no exit CSAs. -Baltimore, MD: Johns Hopkins reported completing 2,548 initial CSAs. The completed CSAs include 2,057 active enrollees and 397 disenrollments. The active enrollees include 960 screening intervention, 959 screening control, 67 treatment intervention, and 71 treatment control. Hopkins conducted 1,120 annual CSAs and 100 exit CSAs. -Hawaii: Moloka'i General Hospital reported that they have completed 449 initial CSAs. The completed CSAs include 382 active enrollees and 57 disenrollments. The active enrollees include 174 screening intervention, 186 screening control, 15 treatment intervention, and 7 treatment control. Moloka'i completed 196 annual CSAs and 179 exit CSAs. -Detroit, MI: Josephine Ford reported 5,579 initial CSAs completed. Of the completed initial CSAs, 4,068 are active enrollees and 1,511 are disenrolled participants. The active enrollees include 1,762 screening intervention, 2,027 screening control, 133 treatment intervention, and 146 treatment control. Ford completed 1,661 annual CSAs and 503 exit CSAs. - Newark, NJ: UMDNJ reported 1,108 initial CSAs completed. The completed initial CSAs include 931 active enrollees and 177 disenrollments. The active enrollees include 873 participants in the screening group and 58 in the treatment group. UMDNJ have completed 373 annual CSAs. -Houston, TX: M.D. Anderson Cancer Center reported 2,059 initial CSAs completed. The completed initial CSAs include 1,782 active enrollees and 277 disenrollments. MDACC's active enrollees include 757 screening intervention, 825 screening control, 101 treatment intervention, and 99 treatment control. The evaluation is well underway. The first Report to Congress was completed in advance of the September 2008 deadline and was been signed by Secretary Leavitt. The second Report to Congress was completed in December 2010. A final report will also be completed by September 2012.